About Us

Scientific Advisors

Agios has assembled a world-class scientific advisory board that includes renowned experts in cancer metabolism, oncology, drug discovery and translational medicine. These advisors work in close collaboration with Agios scientists to identify new research directions and accelerate Agios’ target validation and drug discovery programs.

Lewis C. Cantley, Ph.D.
The Cancer Center at Weill Cornell Medical College and New York-Presbyterian Hospital
Joan Brugge, Ph.D.
Harvard Medical School
Ralph Deberardinis, M.D., Ph.D.
Children's Medical Center Research Institute at UT Southwestern
Matthew Vander Heiden, M.D., Ph.D.
Koch Institute for Integrative Cancer Research at MIT
William G Kaelin, Jr., M.D.
Dana-Farber Cancer Institute and Harvard Medical School
Tak Mak, Ph.D.
University of Toronto and the Campbell Family Institute for Breast Cancer Research
Pier Paolo Pandolfi, M.D., Ph.D.
Beth Israel Deaconess Medical Center
Charles Sawyers, M.D.
Memorial Sloan-Kettering Cancer Center
Shin-San Michael Su, Ph.D.
Former SVP of Research and Development at Agios
Marc Tessler-Lavigne, Ph.D.
Stanford University
Craig B. Thompson, M.D.
Chair of the scientific advisory board, Memorial Sloan-Kettering Cancer Center